Weight loss induced by alpha interferon and gamma interferon

A method for promoting weight loss in a human in need thereof, said method comprising

• administering to said human an effective amount, of a mixture of alpha interferon and gamma interferon to cause the production and release of zinc-α2-glycoproteins from lymphocytes in said human, thereby stimulating lipid breakdown and a reduction of fat stores in said human, such zinc-α2-glycoproteins having a tendency to precipitate with zinc salts and exhibiting electrophoretic mobility in the region of alpha-2 globulins,
• wherein a daily dosage in the range of 50 to 5,000 units of alpha interferon and 50 to 5,000 units of gamma interferon is administered.

A method for causing weight loss in a human comprising administering to said human on a daily basis for a period of time in the range of 3 days to 30 days an effective amount of a weight-loss composition comprising both alpha interferon and gamma interferon to cause weight loss at a greater rate than fasting.

A method for a human to self-induce weight loss comprising self-administering an effective amount of a weight-loss composition comprising both alpha interferon and gamma interferon to cause weight loss at a greater rate than fasting for a period of time in the range of 3 days to 30 days.

A method for a human to self-induce weight loss comprising

• self-administering an effective amount of a weight-loss composition comprising both alpha interferon and gamma interferon to cause weight loss at a greater rate than fasting to 30 days,
• wherein a daily dosage of the weight-loss composition is nasally or buccally, administered over a plurality of applications and the daily dosage is in the range of 50 to 5,000 units of alpha interferon and 50 to 5,000 units of gamma interferon.